Jane Buckner
Physician · Virginia Mason Medical Center
Credentials: · ·
History
2019–Present
- 1991–1992
- 1983–1987
Research
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells
Journal of Clinical Investigation · 2003 · 1,003 citations
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Science Translational Medicine · 2015 · 890 citations
Review · Nature reviews. Immunology · 2010 · Sole author · 628 citations
32 papers
32 papers
- CG
23 papers
22 papers
- GN
21 papers
20 papers · 2 as a fellow
18 papers
- PG
18 papers
Grants
- 2026–2031
Microbial Drivers and Pathogenic Mechanisms in Rheumatoid Arthritis Natural History
National Institute of Allergy and Infectious Diseases · P01
PI · $2.3M · University of Colorado Denver
- 2023–2029
T Cells Promoting Transitions Toward Autoimmunity
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.7M · Benaroya Research Inst at Virginia Mason
- 2023–2028
Regulatory T Cells Maintain Immune Homeostasis Through Translation Control
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.6M · Benaroya Research Inst at Virginia Mason
- 2014–2028
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $144.4M · Benaroya Research Inst at Virginia Mason
Clinical trials
- 2015–2020
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)